17:14 EDT Moleculin Biotech (MBRX) files to sell 64.86M shares of common stock for holders
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech’s Strategic Expansion and Promising Data Support Buy Rating
- Moleculin Biotech Expands Global Phase 2B/3 Trial
- Moleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
- Moleculin Biotech Releases New Corporate Presentation
- Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment